title: Isolation and pharmacological characterisation of papuantoxin-1, a postsynaptic neurotoxin from the venom of the Papuan black snake (Pseudechis papuanus).
abstract: The Papuan black snake (Pseudechis papuanus) is found throughout the southern coastal regions of Papua New Guinea and is thought to occur in the adjacent region of Iriyan Jaya. Neurotoxicity is a major symptom of envenomation by this species. This study describes the isolation of the first neurotoxin papuantoxin-1 from the venom of P. papuanus. Papuantoxin-1 (6738Da), which accounts for approximately 5% of the whole venom, was purified to homogeneity using successive steps of RP-HPLC. The toxin (0.3-1.0 microM) caused concentration dependent inhibition of indirect twitches (0.1 Hz, 0.2 ms and supramaximal V) and inhibited the responses to nicotinic agonists in the chick biventer cervicis nerve-muscle preparation, indicating a postsynaptic mode of action. However, papuantoxin-1 displayed no signs of myotoxicity. Papuantoxin-1 displayed pseudo-irreversible antagonism of cumulative concentration-response curves to carbachol at the skeletal muscle nicotinic receptors with an estimated pA2 value of 6.9+/-0.3. CSL black snake antivenom, which is raised against the venom of the Australian black snake Pseudechis australis, appears to be effective in reversing the effects of papuantoxin-1. Thus, black snake antivenom should be considered for the treatment of the neurotoxic effects following envenomation by the Papaun black snake.
authors: Monash Venom Group, Department of Pharmacology, Monash University, Vic. 3800, Australia.
authors: Sanjaya
authors: S
authors: Kuruppu
authors: Shane
authors: S
authors: Reeve
authors: A Ian
authors: AI
authors: Smith
authors: Wayne C
authors: WC
authors: Hodgson
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002645:Chickens; D004546:Elapid Venoms / Q000032:analysis*; D008970:Molecular Weight; D018482:Muscle, Skeletal / Q000187:drug effects; D009498:Neurotoxins / Q000737:chemistry / Q000302:isolation & purification* / Q000633:toxicity; D010741:Phospholipases A / Q000378:metabolism; D011978:Receptors, Nicotinic / Q000187:drug effects
chemical_list: D004546:Elapid Venoms; D009498:Neurotoxins; D011978:Receptors, Nicotinic; D010741:Phospholipases A